Nucleai
AI-powered spatial biology platform for precision medicine and drug development.
About
Nucleai leverages AI-powered spatial biology to advance precision medicine. Their platform enhances drug development, informs clinical treatment decisions, and aims to improve patient outcomes. They collaborate with pharmaceutical companies and license their research platform for internal use. Teams look it up for Healthcare, Oncology, Pharmaceutical.
Frequently asked
What does Nucleai do?
Nucleai is a Healthcare company that offers Software. Teams look it up for Oncology, Pharmaceutical, HealthTech. It is based in Tel Aviv, Israel and was founded in 2018. Public records show about 66 people and $59M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Nucleai raised?
Nucleai has raised a total of $59M in funding. The most recent round on record is Series B.
Where is Nucleai headquartered?
Nucleai is headquartered in Tel Aviv, Israel.
When was Nucleai founded?
Nucleai was founded in 2018.
What industry does Nucleai operate in?
Nucleai operates in Healthcare, Oncology, Pharmaceutical, HealthTech, MedTech.
How many employees does Nucleai have?
Nucleai has approximately 66 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.